-
Something wrong with this record ?
Dose dependent prophylactic efficacy of 6-chlorotacrine in soman-poisoned mice
J. Kassa, J. Korábečný
Language English Country Czech Republic
Document type Journal Article
Digital library NLK
Volume
Source
NLK
Directory of Open Access Journals
from 1997
Free Medical Journals
from 1997
Open Access Digital Library
from 1997-01-01
Medline Complete (EBSCOhost)
from 2012-06-01
ROAD: Directory of Open Access Scholarly Resources
from 1997
- MeSH
- Antidotes pharmacology MeSH
- Chemically-Induced Disorders prevention & control MeSH
- Cholinesterase Inhibitors poisoning MeSH
- Disease Models, Animal MeSH
- Mice MeSH
- Pre-Exposure Prophylaxis methods MeSH
- Cholinesterase Reactivators pharmacology MeSH
- Soman poisoning MeSH
- Tacrine analogs & derivatives pharmacology MeSH
- Dose-Response Relationship, Drug MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
AIM: The influence of the dose on the ability of promising newly prepared reversible inhibitor of acetylcholinesterase (6-chlorotacrine) to increase the resistance of mice against soman and the efficacy of antidotal treatment of soman-poisoned mice was evaluated. METHODS: The evaluation of the effect of pharmacological pretreatment is based on the identification of changes of soman-induced toxicity that was evaluated by the assessment of its LD50 value and its 95% confidence limit using probit-logarithmical analysis of death occurring within 24 hrs after administration of soman. RESULTS: The dose of 6-chlorotacrine significantly influences the prophylactic efficacy of 6-chlorotacrine. Its highest dose was only able to significantly protect mice against acute toxicity of soman and increase the efficacy of antidotal treatment (atropine in combination with the oxime HI-6) of soman-poisoned mice. In addition, the highest dose of 6-chlorotacrine was significantly more effective to protect mice from soman poisoning than its lowest dose. CONCLUSION: These findings demonstrate the important influence of the dose of 6-chlorotacine on its prophylactic efficacy in the case of pharmacological pretreatment of soman poisoning in mice.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18025601
- 003
- CZ-PrNML
- 005
- 20180810085201.0
- 007
- ta
- 008
- 180711s2017 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.14712/18059694.2018.9 $2 doi
- 035 __
- $a (PubMed)29716679
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Kassa, Jiří, $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, Hradec Králové, Czech Republic $d 1956- $7 mzk2003181395
- 245 10
- $a Dose dependent prophylactic efficacy of 6-chlorotacrine in soman-poisoned mice / $c J. Kassa, J. Korábečný
- 520 9_
- $a AIM: The influence of the dose on the ability of promising newly prepared reversible inhibitor of acetylcholinesterase (6-chlorotacrine) to increase the resistance of mice against soman and the efficacy of antidotal treatment of soman-poisoned mice was evaluated. METHODS: The evaluation of the effect of pharmacological pretreatment is based on the identification of changes of soman-induced toxicity that was evaluated by the assessment of its LD50 value and its 95% confidence limit using probit-logarithmical analysis of death occurring within 24 hrs after administration of soman. RESULTS: The dose of 6-chlorotacrine significantly influences the prophylactic efficacy of 6-chlorotacrine. Its highest dose was only able to significantly protect mice against acute toxicity of soman and increase the efficacy of antidotal treatment (atropine in combination with the oxime HI-6) of soman-poisoned mice. In addition, the highest dose of 6-chlorotacrine was significantly more effective to protect mice from soman poisoning than its lowest dose. CONCLUSION: These findings demonstrate the important influence of the dose of 6-chlorotacine on its prophylactic efficacy in the case of pharmacological pretreatment of soman poisoning in mice.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a antidota $x farmakologie $7 D000931
- 650 _2
- $a chemicky indukované poruchy $x prevence a kontrola $7 D064419
- 650 _2
- $a cholinesterasové inhibitory $x otrava $7 D002800
- 650 _2
- $a reaktivátory cholinesterasy $x farmakologie $7 D002801
- 650 _2
- $a modely nemocí na zvířatech $7 D004195
- 650 _2
- $a vztah mezi dávkou a účinkem léčiva $7 D004305
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a preexpoziční profylaxe $x metody $7 D065129
- 650 _2
- $a soman $x otrava $7 D012999
- 650 _2
- $a takrin $x analogy a deriváty $x farmakologie $7 D013619
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Korábečný, Jan $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, Hradec Králové, Czech Republic $7 xx0119837
- 773 0_
- $w MED00010947 $t Acta Medica (Hradec Kralove) $x 1211-4286 $g Roč. 60, č. 4 (2017), s. 140-145
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/29716679 $y Pubmed
- 856 41
- $u https://actamedica.lfhk.cuni.cz/media/pdf/am_2017060040140.pdf $y plný text volně přístupný
- 910 __
- $a ABA008 $b A 3077 $c 1072 $y 4 $z 0
- 990 __
- $a 20180711 $b ABA008
- 991 __
- $a 20180723125256 $b ABA008
- 999 __
- $a ok $b bmc $g 1324918 $s 1022523
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 60 $c 4 $d 140-145 $i 1211-4286 $m Acta Medica $n Acta Med. (Hradec Král.) $x MED00010947
- LZP __
- $b NLK118 $a Pubmed-20180711